Clinical Trial Update: Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1b study of CCX872-B in pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CCX872-B

Snippet

Sponsor: Amgen | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED